Apollomics (APLM) COO Chen Yi‑Kuei Receives Award, Exercises Options

What Happened
Chen Yi‑Kuei, Chief Operating Officer of Apollomics Inc. (APLM), received an 8,000‑share derivative award on Sep 14, 2026 (stock option under the 2023 Incentive Award Plan) and experienced related derivative activity on Sep 15, 2026. The filing reports: a 5,000‑share acquisition via exercise/conversion of a derivative (reported at $0.00), an 8,000‑share grant (reported at $0.00), and a same‑day 5,000‑share disposition (reported at $0.00). Reported dollar values for these transactions are $0.00.

Key Details

• Transaction dates & types: Sep 14, 2026 — Grant/award of 8,000 shares (derivative, $0.00); Sep 15, 2026 — Exercise/conversion (acquire) of 5,000 shares (derivative, $0.00) and exercise/conversion (dispose) of 5,000 shares (derivative, $0.00).
• Shares owned after transaction: Not specified in the Form 4 (not disclosed in the provided filing text).
• Notable footnotes:
  • F3: The 8,000‑share stock option (granted 9/14/2026) vests 50% on 3/14/2027 and 50% on 9/14/2027, subject to continued service.
  • F4: Each RSU represents a contingent right to one Class A Ordinary Share.
  • F5: The 5,000‑share reported conversion on 9/15/2026 represents the vesting of 5,000 RSUs (part of a previously reported RSU grant).
  • F1: A 100‑share adjustment was made for shares previously omitted.
• Filing status: This is an amended Form 4 filed Sep 24, 2026 to correct the option expiration date and clarify ownership; the reported transactions occurred Sep 14–15, 2026 (the filing date is beyond the typical two‑business‑day window for Form 4s).

Context

• The filing documents derivative activity (RSU vesting and a stock option grant). RSU vesting converts conditional units into shares; the report also shows a same‑day disposition of 5,000 shares (the Form 4 does not specify the reason for the disposition, e.g., tax withholding or sale).
• The 8,000‑share option has a one‑year vesting schedule (50% at six months, 50% at 12 months) and does not immediately represent freely tradable shares until vested and exercised.
• This is an amended report correcting prior details; no cash value is reported for these specific entries.